Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 628.00
-9.00 (-1.41%)
Jul 22, 2025, 3:30 PM JST
Japan Tissue Engineering Revenue
In the fiscal year ending March 31, 2025, Japan Tissue Engineering had annual revenue of 2.46B JPY, down -2.35%. Japan Tissue Engineering had revenue of 748.58M in the quarter ending March 31, 2025, with 2.69% growth.
Revenue
2.46B
Revenue Growth
-2.35%
P/S Ratio
10.39
Revenue / Employee
12.03M
Employees
204
Market Cap
25.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.46B | -59.00M | -2.35% |
| Mar 31, 2024 | 2.51B | 482.00M | 23.72% |
| Mar 31, 2023 | 2.03B | -71.00M | -3.38% |
| Mar 31, 2022 | 2.10B | -154.00M | -6.82% |
| Mar 31, 2021 | 2.26B | -52.00M | -2.25% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |